To develop an evidence-based healthcare practice with a patient-centred culture, providing personalised THS (total health solutions) through integrated approaches, anchoring on Hong Kong’s reputation in medical services & Macau’s unrivalled medical tourism infrastructure serving the Greater Bay Area and key cities in China.
Bringing together doctors of different specialties and allied health professionals of different disciplines, Virtus offers a broad array of healthcare and medical services that encompass different stages of the health cycle, from wellness and prevention, diagnosis, treatment, to rehabilitation.
Wellness and Prevention: The road to good health begins with health protection and disease prevention. Virtus offers a wide range of vaccination and health check programmes to ensure our clients are well looked after. Virtus promotes the concept of “food is medicine” and “sport is medicine”. Our registered dietitians and physiotherapists customize each consultation to provide dietary and physical exercise advice that is tailored to individual needs.
Diagnosis: Early detection of disease is of vital importance. Virtus provides multiple diagnostic services with the support of advanced equipment and technologies to allow swift intervention.
Treatment: Virtus’s wide range of specialists work together to deliver cross-disciplinary and holistic therapeutic solutions to patients who expect the highest level of medical care.
Rehabilitation: Rehabilitation and treatment go hand in hand. Virtus’s rehabilitation programme for each of our patients is provided by a multidisciplinary allied health team coordinated by a dedicated health consultant.
Shareholders of Virtus are comprised of leading institutional investors including Cenova Capital, GIC and Samena Capital, and doctors and managements of the Group.
About Cenova Capital (www.cenovaventures.com)
Cenova Capital is one of the earliest healthcare dedicated funds in China, founded in 2010 to provide thoughtful and connected capital to transform China’s healthcare industry. As a value-oriented investor, Cenova uses a methodical, research-based approach to uncover unique proprietary investment opportunities, and build synergies across its portfolio. Currently, Cenova has four funds under management with a combined AUM of over USD600 million invested in over 40 companies in the life sciences and healthcare product and services sectors, including directly or indirectly more than 30 hospitals in Mainland China. Guided by the principles of putting the interests of its stakeholders first, and committed to performance and returning capital to its investors, Cenova aims to be the partner of choice.
About GIC (www.gic.com.sg)
GIC is a leading global investment firm established in 1981 to manage Singapore’s foreign reserves. As a long-term value investor, GIC is uniquely positioned for investments across a wide range of asset classes, including equities, fixed income, private equity, real estate and infrastructure. GIC has investments in over 40 countries and has been investing in emerging markets for more than two decades. Headquartered in Singapore, GIC employs over 1,500 people across 10 offices in key financial cities worldwide. For more information about GIC, please visit www.gic.com.sg.
About Samena Capital (www.samenacapital.com)
Samena Capital is a principal investment group focusing on the Subcontinent, Asia, Middle East and North Africa (collectively, the SAMENA region). The firm has raised more than USD 1.5 billion of capital since 2008 and has returned USD 615 million to investors from over 45 full and partial exits. Samena Capital currently manages total capital of approximately USD1.0 billion across three primary investment strategies: private equity, direct investments, and credit.